PFE

Pfizer Inc. $27.72 1M +5.4% 3M +5.9% YTD +10.1% as of 2026-09-11
+Watchlist

next ticker · + or scroll to zoom · pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings beat miss  ·  ring before open after close  ·  moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.2%
Next 1 week
-0.0%
Next 1 month
+0.0%
Seasonality
Mildly positive window
Next 30 days (to Oct 13): +0.8% median, 53% of the last 53 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 31
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.01%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.34 +0.1% · Seasonal tilt -0.1%
$157.1B market cap (#74 US) $916M/day volume 24% volatility +13% 1-year -55% from ATH
52-week range · 74% of the way up · -5% from the high
$23.58$29.21

Congressional trades in PFE Full tracker →

67 members · 121 buys / 174 sells · $1.7M–$7.7M disclosed · latest filing Aug 13, 2026.

SELL CM Carol Devine Miller · traded Mar 10, 2025 $15K–$50K
SELL MR Michael Rulli · traded Nov 26, 2024 $1K–$15K
SELL TT Thomas H Tuberville · traded May 3, 2024 $15K–$50K
SELL AA Alan Armstrong · traded Mar 24, 2026 $50K–$100K
SELL TT Thomas H Tuberville · traded Jun 8, 2026 $15K–$50K
SELL GC Gilbert Cisneros · traded Mar 13, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Feb 10, 2026 $1K–$15K
SELL JH James French Hill · traded Dec 31, 2025 $100K–$250K

Earnings Full history →

Next report 2026-11-03 (Tuesday, before open, in 51 days) · EPS est. 0.76.

1-day std dev
2.5%
Finished up
47%
Biggest pop
+6.1%
Biggest drop
-5.0%

Standard deviation of the close-to-close move over the last 60 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.